Delivery Order SPE2DB22D2006-SPE2DB24FW0BM
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,612.34 for Ozempic 0.25-0.5 mg/dose pens. The award was made by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of January 8, 2024 and uses a firm fixed price pricing structure. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The $3,483.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 12, 2023, with a period of performance through July 13, 2023. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml volume. The Firm Fixed Price contract, valued at $14,519.97, has an ultimate completion date of August 29, 2023. This is a Delivery Order awarded under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $3,697.45 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on May 19, 2023, with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,702.93 for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 10, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $9,297.54 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen with a 3 mL capacity. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $8,995.20 Firm Fixed Price Delivery Order for the supply of Ozempic 0.25-0.5 mg/dose pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, on February 14, 2024, with a completion date of February 15, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,610.44 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order (SPE2DX15D3202|SPE2DX24F2LP5) valued at $6,341.04 for the provision of Ozempic 0.25-0.5 mg/dose pens (3 mL). The contract is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract has a ceiling value of $1,667.26 and an ultimate completion date of April 29, 2024. The contract is a delivery order with a firm fixed-price pricing type, awarded by the Defense Logistics Agency (DLA) Troop Support Medical. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FW0BMDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The $51,308.77 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 6, 2024. The contract is not designated as a set-aside award. Amerisourcebergen is the prime contractor for this delivery order, which is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.3k | 5/3/24 |